(Q33144725)

22 July 2017

title

Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy (English)

1 reference

hypertrophic cardiomyopathy

22 July 2017

0 references

1 reference

1 reference

inferred from title

ventricular tachycardia

1 reference

Elliott PM

1

1 reference

22 July 2017

Sharma S

2

1 reference

22 July 2017

Varnava A

3

1 reference

22 July 2017

Poloniecki J

4

1 reference

22 July 2017

Rowland E

5

1 reference

22 July 2017

McKenna WJ

6

1 reference

22 July 2017

language of work or name

English

0 references

publication date

1 May 1999

1 reference

Journal of the American College of Cardiology

22 July 2017

published in

1 reference

22 July 2017

volume

33

1 reference

22 July 2017

issue

6

1 reference

22 July 2017

page(s)

1596-1601

1 reference

The management of hypertrophic cardiomyopathy

22 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900056-X

7 January 2021

Prognosis in hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and hemodynamic features

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900056-X

7 January 2021

Arrhythmia and prognosis in infants, children and adolescents with hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900056-X

7 January 2021

Clinical course and prognosis of hypertrophic cardiomyopathy in an outpatient population

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900056-X

7 January 2021

Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected regional population.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900056-X

7 January 2021

Natural history of hypertrophic cardiomyopathy. A population-based study, 1976 through 1990.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900056-X

7 January 2021

Long-term outcome of patients with hypertrophic cardiomyopathy successfully resuscitated after cardiac arrest

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900056-X

7 January 2021

Prognostic implications of novel beta cardiac myosin heavy chain gene mutations that cause familial hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900056-X

7 January 2021

Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900056-X

7 January 2021

Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900056-X

7 January 2021

Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900056-X

7 January 2021

Distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: a two-dimensional echocardiographic study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900056-X

7 January 2021

Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy. A wide angle, two dimensional echocardiographic study of 125 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900056-X

7 January 2021

Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900056-X

7 January 2021

Mechanisms of exercise limitation in hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900056-X

7 January 2021

Abnormal blood pressure response during exercise in hypertrophic cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900056-X

7 January 2021

Arrhythmia in hypertrophic cardiomyopathy. I: Influence on prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900056-X

7 January 2021

Prognostic significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900056-X

7 January 2021

Prospective prognostic assessment of blood pressure response during exercise in patients with hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900056-X

7 January 2021

Abnormal vascular responses to supine exercise in hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900056-X

7 January 2021

Cardiac arrest in an adolescent with atrial fibrillation and hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900056-X

7 January 2021

Hypertrophic cardiomyopathy and sudden death

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900056-X

7 January 2021

The automatic implantable cardioverter-defibrillator in young patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900056-X

7 January 2021

Sudden cardiac death and the use of implantable cardioverter-defibrillators in pediatric patients. The Pediatric Electrophysiology Society

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900056-X

7 January 2021

Hypertrophic cardiomyopathy: role of the implantable cardioverter-defibrillator

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900056-X

7 January 2021

The value of electrophysiology study and prophylactic implantation of cardioverter defibrillator in patients with hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900056-X

7 January 2021

Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900056-X

7 January 2021

Sudden death during empiric amiodarone therapy in symptomatic hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900056-X

7 January 2021

10.1016/S0735-1097(99)00056-X

Identifiers

DOI

1 reference

22 July 2017

1 reference